Literature DB >> 21983427

Chronic subhepatotoxic exposure to arsenic enhances hepatic injury caused by high fat diet in mice.

Min Tan1, Robin H Schmidt, Juliane I Beier, Walter H Watson, Hai Zhong, J Christopher States, Gavin E Arteel.   

Abstract

Arsenic is a ubiquitous contaminant in drinking water. Whereas arsenic can be directly hepatotoxic, the concentrations/doses required are generally higher than present in the US water supply. However, physiological/biochemical changes that are alone pathologically inert can enhance the hepatotoxic response to a subsequent stimulus. Such a '2-hit' paradigm is best exemplified in chronic fatty liver diseases. Here, the hypothesis that low arsenic exposure sensitizes liver to hepatotoxicity in a mouse model of non-alcoholic fatty liver disease was tested. Accordingly, male C57Bl/6J mice were exposed to low fat diet (LFD; 13% calories as fat) or high fat diet (HFD; 42% calories as fat) and tap water or arsenic (4.9 ppm as sodium arsenite) for ten weeks. Biochemical and histologic indices of liver damage were determined. High fat diet (± arsenic) significantly increased body weight gain in mice compared with low-fat controls. HFD significantly increased liver to body weight ratios; this variable was unaffected by arsenic exposure. HFD caused steatohepatitis, as indicated by histological assessment and by increases in plasma ALT and AST. Although arsenic exposure had no effect on indices of liver damage in LFD-fed animals, it significantly increased the liver damage caused by HFD. This effect of arsenic correlated with enhanced inflammation and fibrin extracellular matrix (ECM) deposition. These data indicate that subhepatotoxic arsenic exposure enhances the toxicity of HFD. These results also suggest that arsenic exposure might be a risk factor for the development of fatty liver disease in human populations.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21983427      PMCID: PMC3232462          DOI: 10.1016/j.taap.2011.09.019

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  38 in total

1.  Hepatic damage caused by chronic arsenic toxicity in experimental animals.

Authors:  A Santra; A Maiti; S Das; S Lahiri; S K Charkaborty; D N Mazumder
Journal:  J Toxicol Clin Toxicol       Date:  2000

2.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

3.  Hepatic manifestations in chronic arsenic toxicity.

Authors:  A Santra; J Das Gupta; B K De; B Roy; D N Guha Mazumder
Journal:  Indian J Gastroenterol       Date:  1999 Oct-Nov

Review 4.  The role of cytokines in non-alcoholic fatty liver disease.

Authors:  Herbert Tilg
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

5.  Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.

Authors:  Kristiaan Wouters; Patrick J van Gorp; Veerle Bieghs; Marion J Gijbels; Hans Duimel; Dieter Lütjohann; Anja Kerksiek; Roger van Kruchten; Nobuyo Maeda; Bart Staels; Marc van Bilsen; Ronit Shiri-Sverdlov; Marten H Hofker
Journal:  Hepatology       Date:  2008-08       Impact factor: 17.425

6.  Rejoinder: Arsenic exposure and prevalence of type 2 diabetes: updated findings from the National Health Nutrition and Examination Survey, 2003-2006.

Authors:  Ana Navas-Acien; Ellen K Silbergeld; Roberto Pastor-Barriuso; Eliseo Guallar
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

7.  Identifying US populations for the study of health effects related to drinking water arsenic.

Authors:  Floyd J Frost; Timothy Muller; Hans V Petersen; Bruce Thomson; Kristine Tollestrup
Journal:  J Expo Anal Environ Epidemiol       Date:  2003-05

8.  Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero.

Authors:  Michael P Waalkes; Jie Liu; Hua Chen; Yaxiong Xie; William E Achanzar; Yun-Su Zhou; Min-Liang Cheng; Bhalchandra A Diwan
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

9.  PKCepsilon plays a causal role in acute ethanol-induced steatosis.

Authors:  J Phillip Kaiser; Juliane I Beier; Jun Zhang; J David Hoetker; Claudia von Montfort; Luping Guo; Yuting Zheng; Brett P Monia; Aruni Bhatnagar; Gavin E Arteel
Journal:  Arch Biochem Biophys       Date:  2008-11-11       Impact factor: 4.013

10.  Characterization of the impaired glucose homeostasis produced in C57BL/6 mice by chronic exposure to arsenic and high-fat diet.

Authors:  David S Paul; Felecia S Walton; R Jesse Saunders; Miroslav Stýblo
Journal:  Environ Health Perspect       Date:  2011-05-18       Impact factor: 9.031

View more
  34 in total

Review 1.  Mechanisms of Environmental Contributions to Fatty Liver Disease.

Authors:  Banrida Wahlang; Jian Jin; Juliane I Beier; Josiah E Hardesty; Erica F Daly; Regina D Schnegelberger; K Cameron Falkner; Russell A Prough; Irina A Kirpich; Matthew C Cave
Journal:  Curr Environ Health Rep       Date:  2019-09

2.  Chronic exposure to arsenic and high fat diet induces sex-dependent pathogenic effects on the kidney.

Authors:  Yixian Zhang; Jamie L Young; Lu Cai; Yong Guang Tong; Lining Miao; Jonathan H Freedman
Journal:  Chem Biol Interact       Date:  2019-06-22       Impact factor: 5.192

3.  The impact of BMI on non-malignant respiratory symptoms and lung function in arsenic exposed adults of Northern Chile.

Authors:  Anthony Nardone; Catterina Ferreccio; Johanna Acevedo; Wayne Enanoria; Alden Blair; Allan H Smith; John Balmes; Craig Steinmaus
Journal:  Environ Res       Date:  2017-07-21       Impact factor: 6.498

4.  Olanzapine-induced liver injury in mice: aggravation by high-fat diet and protection with sulforaphane.

Authors:  Robin H Isaacson; Juliane I Beier; Nicholas Kh Khoo; Bruce A Freeman; Zachary Freyberg; Gavin E Arteel
Journal:  J Nutr Biochem       Date:  2020-04-08       Impact factor: 6.048

5.  MetPP: a computational platform for comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry-based metabolomics.

Authors:  Xiaoli Wei; Xue Shi; Imhoi Koo; Seongho Kim; Robin H Schmidt; Gavin E Arteel; Walter H Watson; Craig McClain; Xiang Zhang
Journal:  Bioinformatics       Date:  2013-05-11       Impact factor: 6.937

6.  Oligofructose protects against arsenic-induced liver injury in a model of environment/obesity interaction.

Authors:  Veronica L Massey; Kendall S Stocke; Robin H Schmidt; Min Tan; Nadim Ajami; Rachel E Neal; Joseph F Petrosino; Shirish Barve; Gavin E Arteel
Journal:  Toxicol Appl Pharmacol       Date:  2015-03-08       Impact factor: 4.219

7.  Adipose tissue-liver crosstalk during pathologic changes caused by vinyl chloride metabolites in mice.

Authors:  Brenna R Kaelin; Collin M McKenzie; Karl W Hempel; Anna L Lang; Gavin E Arteel; Juliane I Beier
Journal:  Toxicol Appl Pharmacol       Date:  2020-05-20       Impact factor: 4.219

8.  Hepatic transcriptomic responses in mice exposed to arsenic and different fat diet.

Authors:  Hui Hou; Yue Yu; Zhuoyan Shen; Su Liu; Bing Wu
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-10       Impact factor: 4.223

9.  Metabolomic analysis of the effects of chronic arsenic exposure in a mouse model of diet-induced Fatty liver disease.

Authors:  Xiang Zhang; Walter H Watson; Xue Shi; Xiaoli Wei; Imhoi Koo; Robin H Schmidt; Xinmin Yin; Seong Ho Kim; Andrew Vaughn; Craig J McClain; Gavin E Arteel
Journal:  J Proteome Res       Date:  2013-12-17       Impact factor: 4.466

10.  From the Cover: Arsenite Uncouples Mitochondrial Respiration and Induces a Warburg-like Effect in Caenorhabditis elegans.

Authors:  Anthony L Luz; Tewodros R Godebo; Dhaval P Bhatt; Olga R Ilkayeva; Laura L Maurer; Matthew D Hirschey; Joel N Meyer
Journal:  Toxicol Sci       Date:  2016-05-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.